These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 37189604)

  • 41. The Role of Nonglycolytic Glucose Metabolism in Myocardial Recovery Upon Mechanical Unloading and Circulatory Support in Chronic Heart Failure.
    Badolia R; Ramadurai DKA; Abel ED; Ferrin P; Taleb I; Shankar TS; Krokidi AT; Navankasattusas S; McKellar SH; Yin M; Kfoury AG; Wever-Pinzon O; Fang JC; Selzman CH; Chaudhuri D; Rutter J; Drakos SG
    Circulation; 2020 Jul; 142(3):259-274. PubMed ID: 32351122
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dobutamine stress echocardiography predicts myocardial improvement in patients supported by left ventricular assist devices (LVADs): hemodynamic and histologic evidence of improvement before LVAD explantation.
    Khan T; Delgado RM; Radovancevic B; Torre-Amione G; Abrams J; Miller K; Myers T; Okerberg K; Stetson SJ; Gregoric I; Hernandez A; Frazier OH
    J Heart Lung Transplant; 2003 Feb; 22(2):137-46. PubMed ID: 12581761
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Machine Learning-Based Prediction of Myocardial Recovery in Patients With Left Ventricular Assist Device Support.
    Topkara VK; Elias P; Jain R; Sayer G; Burkhoff D; Uriel N
    Circ Heart Fail; 2022 Jan; 15(1):e008711. PubMed ID: 34949101
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Continued versus Suspended Cardiac Resynchronization Therapy after Left Ventricular Assist Device Implantation.
    Roukoz H; Bhan A; Ravichandran A; Ahmed MM; Bhat G; Cowger J; Abdullah M; Dhawan R; Trivedi JR; Slaughter MS; Gopinathannair R
    Sci Rep; 2020 Feb; 10(1):2573. PubMed ID: 32054868
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association between biventricular pacing and incidence of ventricular arrhythmias in the early post-operative period after left ventricular assist device implantation.
    Chou A; Larson J; Deshmukh A; Cascino TM; Ghannam M; Latchamsetty R; Jongnarangsin K; Oral H; Morady F; Bogun F; Aaronson KD; Pagani FD; Liang JJ
    J Cardiovasc Electrophysiol; 2022 May; 33(5):1024-1031. PubMed ID: 35245401
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Effect of Left Ventricular Assist Device Therapy on Cardiac Biomarkers: Implications for the Identification of Myocardial Recovery.
    Holzhauser L; Kim G; Sayer G; Uriel N
    Curr Heart Fail Rep; 2018 Aug; 15(4):250-259. PubMed ID: 29971612
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gene transfection with human hepatocyte growth factor complementary DNA plasmids attenuates cardiac remodeling after acute myocardial infarction in goat hearts implanted with ventricular assist devices.
    Shirakawa Y; Sawa Y; Takewa Y; Tatsumi E; Kaneda Y; Taenaka Y; Matsuda H
    J Thorac Cardiovasc Surg; 2005 Sep; 130(3):624-32. PubMed ID: 16153905
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Myocardial fibrosis and pro-fibrotic markers in end-stage heart failure patients during continuous-flow left ventricular assist device support.
    Lok SI; Nous FM; van Kuik J; van der Weide P; Winkens B; Kemperman H; Huisman A; Lahpor JR; de Weger RA; de Jonge N
    Eur J Cardiothorac Surg; 2015 Sep; 48(3):407-15. PubMed ID: 25609773
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Left ventricular assist devices (LVAD): optional treatment alternative to cardiac transplantation?].
    Wohlschlaeger J; Kawaguchi N; Levkau B; Schmid C; Scheld HH; Baba HA
    Verh Dtsch Ges Pathol; 2004; 88():113-21. PubMed ID: 16892541
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(16):1-167. PubMed ID: 23074467
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of right and left ventricular responses to left ventricular assist device support in patients with severe heart failure: a primary role of mechanical unloading underlying reverse remodeling.
    Barbone A; Holmes JW; Heerdt PM; The' AH; Naka Y; Joshi N; Daines M; Marks AR; Oz MC; Burkhoff D
    Circulation; 2001 Aug; 104(6):670-5. PubMed ID: 11489773
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Implantable defibrillators improve survival in patients with mildly symptomatic heart failure receiving cardiac resynchronization therapy: analysis of the long-term follow-up of remodeling in systolic left ventricular dysfunction (REVERSE).
    Gold MR; Daubert JC; Abraham WT; Hassager C; Dinerman JL; Hudnall JH; Cerkvenik J; Linde C
    Circ Arrhythm Electrophysiol; 2013 Dec; 6(6):1163-8. PubMed ID: 24125796
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dependency of cardiac resynchronization therapy on myocardial viability at the LV lead position.
    Becker M; Zwicker C; Kaminski M; Napp A; Altiok E; Ocklenburg C; Friedman Z; Adam D; Schauerte P; Marx N; Hoffmann R
    JACC Cardiovasc Imaging; 2011 Apr; 4(4):366-74. PubMed ID: 21492811
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Changes in sarcomeric and non-sarcomeric cytoskeletal proteins and focal adhesion molecules during clinical myocardial recovery after left ventricular assist device support.
    Latif N; Yacoub MH; George R; Barton PJ; Birks EJ
    J Heart Lung Transplant; 2007 Mar; 26(3):230-5. PubMed ID: 17346624
    [TBL] [Abstract][Full Text] [Related]  

  • 55. LVAD-induced reverse remodeling: basic and clinical implications for myocardial recovery.
    Burkhoff D; Klotz S; Mancini DM
    J Card Fail; 2006 Apr; 12(3):227-39. PubMed ID: 16624689
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Low incidence of myocardial recovery after left ventricular assist device implantation in patients with chronic heart failure.
    Mancini DM; Beniaminovitz A; Levin H; Catanese K; Flannery M; DiTullio M; Savin S; Cordisco ME; Rose E; Oz M
    Circulation; 1998 Dec; 98(22):2383-9. PubMed ID: 9832482
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of continuous-flow versus pulsatile-flow left ventricular assist devices on myocardial unloading and remodeling.
    Kato TS; Chokshi A; Singh P; Khawaja T; Cheema F; Akashi H; Shahzad K; Iwata S; Homma S; Takayama H; Naka Y; Jorde U; Farr M; Mancini DM; Schulze PC
    Circ Heart Fail; 2011 Sep; 4(5):546-53. PubMed ID: 21765125
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cardiac Resynchronization Therapy Optimization: A Comprehensive Approach.
    Katbeh A; Van Camp G; Barbato E; Galderisi M; Trimarco B; Bartunek J; Vanderheyden M; Penicka M
    Cardiology; 2019; 142(2):116-128. PubMed ID: 31117077
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Biventricular assist device-induced right ventricular reverse structural and functional remodeling.
    Klotz S; Naka Y; Oz MC; Burkhoff D
    J Heart Lung Transplant; 2005 Sep; 24(9):1195-201. PubMed ID: 16143233
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Outcomes of patients after successful left ventricular assist device explantation: a EUROMACS study.
    Antonides CFJ; Schoenrath F; de By TMMH; Muslem R; Veen K; Yalcin YC; Netuka I; Gummert J; Potapov EV; Meyns B; Özbaran M; Schibilsky D; Caliskan K;
    ESC Heart Fail; 2020 Jun; 7(3):1085-1094. PubMed ID: 32196996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.